Mycophenolate-MMF (MPA)

This test measures the amount of mycophenolic acid in your blood. Mycophenolic acid is the active form of the medicine mycophenolate mofetil, a key antirejection drug used after organ transplantation. The measurement helps your care team understand how your body absorbs, processes, and clears the medicine so your dose can be tailored to you.

Blood is usually drawn just before your next scheduled dose, often called a trough sample, so the result reflects the lowest concentration during a dosing cycle. Levels can vary with time after a dose, other medications, albumin levels, and how your gut absorbs the drug.

Finding the right exposure to mycophenolic acid helps protect your transplant while limiting side effects. Results guide dosing when therapy is started, when doses change, when other medicines are added or removed, or when there are concerns about rejection or toxicity. This test supports individualized dosing across different transplant types and clinical situations.

Keeping the exposure in an intended range reduces the chance of rejection while helping to avoid problems such as stomach upset, infections, or low blood counts. Your result is interpreted together with other labs and clinical findings, and with attention to medicines that are taken with mycophenolate.

Your care team interprets your result based on when the blood was drawn, your dosing schedule, and your other medicines. If the level appears lower than intended, they may discuss timing of the sample, missed doses, stomach or bowel symptoms, or drug interactions, and may adjust your dose or repeat the test.

If the level appears higher than intended or you have side effects, your team may adjust dosing, review interacting drugs, or check additional labs such as kidney function and blood counts. Do not change your dose on your own. Tell the clinic if you took a dose late or early, or if you were ill around the time of the blood draw so they can interpret the result accurately.